Class 2 Recall on Valsartan

Teva UK Limited and Mylan are recalling some Valsartan containing products including certain batches supplied by Teva UK Limited and all unexpired batches supplied by Mylan.

Class 4 Recall on Zoledronic acid 5mg solution for infusion

Ranbaxy (UK) Ltd a Sun Pharmaceutical Company, has informed us that some packs from the above batch contain a Patient Information Leaflet (PIL) for Temozolomide 180mg Capsules..

Please visit the: MHRA website for more details on this drug alert.

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch

1186964Zoledronic acid 5mg solution for infusionRanbaxy (UK) LtdJKT1576A

For any enquiries, please contact Ranbaxy / Sun Pharmaceuticals customer services team: Tel: 020 8848 5050; email: cserv.uk@sunpharma.com.
 

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

This is a caution in use only and therefore we are not accepting stock returns.

If you have any questions, then please contact your local Service Centre Customer Services team.

Class 2 Recall on Ranitidine 150mg & 300mg Tabs Accord Healthcare

Accord Healthcare are recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity Nnitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.

Class 2 Recall on Paracetamol 500mg (1000s) M&A Pharma

M & A Pharmachem is recalling the above batches as a precautionary measure, because a small number of pots from some batches have been found to contain discoloured tablets due to fungal contamination. The fungus has been identified as Penicillium citrinum. It is unlikely that any affected tablets will have got to patient level as the discolouration is noticeable on opening affected packs.

Class 3 Drug Alert (Action Within 5 Days) Taxotere Concentrate 80mg per 4ml

Sanofi are recalling the listed batches of Taxotere (Docetaxel) Concentrate due to a production fault potentially leading to an increase in the concentration of Docetaxel in the solution.

Class 3 Drug Alert (Action Within 5 Days) Algivon Alg Strl Drsg 10cmsq X 5

Advancis Medical Ltd are recalling the below batch due to the potential packaging integrity.

Class 4 Drug Alert (Caution in use only) Convulex 500mg Capusles

G.L. Pharma GmbH would like to inform Healthcare professionals that they are aware that there is an error on the carton for batches 5E048A and 5H155A in relation to the strength. Inadvertently, the information "Each capsule contains 150 mg valproic acid." was printed on one side of the cartons instead of the correct "Each capsule contains 500 mg valproic acid." All other information, especially the main headings on the package ("Convulex® capsules 500 mg"), however is correct on the carton. G.L. Pharma GmbH confirms that capsules are 500mg strength. The correct strength is also given on the primary blister pack and the patient information leaflet. G.L. Pharma GmbH have informed the MHRA and the MHRA have approved the continued distribution of batches 5E048A and 5H155A until replacement stock is available.

Company-Led Dotarem Solution for Injection 15ml

GUERBERT have issued a precautionary recall because a glass particle has been identified in one syringe from this batch..

Company-Led Drug Alert Fludarabine 25mg/ml, 1 x 2ml

Sandoz is recalling this batch because particulate matter, believed to be intrinsic to the active pharmaceutical ingredient, was identified in samples.

Class 4 Drug Alert (Caution in use only) Genotropin Goquick 5.3mg and Genotropin Goquick 12mg

Pfizer Limited has notified us of a manufacturing defect in the dosing mechanism of some Genotropin GoQuick pens which are used to administer somatropin.